We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
VTAMA ORGANON PHARMA PTY LTD
Product name
VTAMA
Sponsor
Accepted date
Oct-2025
Active ingredients
tapinarof
Proposed indication
Vtama (tapinarof) is proposed to treat atopic dermatitis (a type of eczema) in adults and children aged 2 and older. Vtama is also proposed to treat plaque psoriasis (a skin condition that causes scaly patches) in adults.
Application type
A (new medicine)
Publication date
Oct-2025